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ABSTRACT
Objectives: This study was designed to evaluate the
impact of introducing a managed vision beneﬁt program
on the use and costs of vision services in a managed care
setting and also to assess satisfaction with those services
after the program was introduced.
Methods: Utilization and costs were compared for two
groups of patients. The comparison group (n = 36,168)
included all patients enrolled for 18 months before imple-
mentation of the managed eye-care plan. The study group
(n = 23,816) included those enrolled for 18 months fol-
lowing its implementation. Medical claims, survey, and
administrative data were used to evaluate study outcomes.
Results: The overall use of vision care was similar before
and after the introduction of the managed eye-care pro-
grams, with 24% of each group receiving at least one
vision service during the 18-month period. Nevertheless,
an increase in the use of routine eye-care services and a
decrease in medical eye-care services were observed fol-
lowing program implementation. The overall cost of pro-
viding eye-care services to patients decreased from $1.86
to $1.36 per member per month after the program
started, largely owing to a reduction in spending associ-
ated with medical eye-care services. More than 90% of
patients surveyed were satisﬁed with their vision care pro-
vided by the program.
Conclusions: Findings suggest that introducing routine
and medical managed eye-care programs in a managed
care setting allows for a reduction in medical costs while
maintaining access to care and patient satisfaction.
Keywords: managed eye-care program, medical claims,
medical eye-care costs, patient satisfaction, vision service
use.
Introduction
Vision impairment and blindness impose a consid-
erable economic and social burden on society. The
prevalence of legal blindness or vision impairment
among those 40 or over in the United States has
been estimated at 2.85% [1]. Impaired vision con-
tributes to diminished worker productivity,
decreased functioning, and an increased likelihood
of injury [2]. Eye and vision problems have been
reported to occur in as many as 70% to 75% of
computer workers [3]. In addition, uncorrected
refractive error, the most common cause of vision
impairment, can reduce functional performance,
increase the number of preventable injuries, and
diminish quality of life [2]. In fact, medical eye-care
costs have a considerable impact on our health-care
system. For example, Health Care Financing
Administration data show that ophthalmology serv-
ices represented nearly 5% or $3.2 billion of Medi-
care Part-B payments in 2001 [4].
An estimated 33.7 million visits are made each
year to ofﬁce-based physicians in the United States
for medical care of eye disorders. Further, according
to the Occupational Health and Safety Administra-
tion, approximately 1000 eye injuries occur daily
and result in an estimated $300 million annually in
direct medical costs and indirect costs related to lost
productivity [5].
Many vision disorders can be identiﬁed and
effectively treated through routine eye exams. Nev-
ertheless, there is a high unmet need for vision care.
Results from a nationally based access-to-care sur-
vey showed that approximately 14 million individ-
uals confront barriers to receiving eyeglasses [6].
The Bureau of Labor Statistics has reported that
only 26% of full-time employees and 9% of part-
time employees working in medium and large pri-
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vate companies had a vision care beneﬁt in 1997
[7]. Nevertheless, there is an increasing trend
toward providing employees with vision care cov-
erage [5,7]. Recent data indicated that 67% of 580
large companies surveyed offered a structured man-
aged eye-care program to their employees [7].
As the ﬁnancing and delivery of health care con-
tinues to evolve and the proportion of patients
receiving health care services from managed care
organizations (MCOs) continues to rise, it is impor-
tant to ensure that high-quality health care be made
available to patients. Although several studies have
examined the effects of managed care versus tradi-
tional indemnity care on patient outcomes and costs
[8,9], there is a notable absence in the literature of
studies examining the effects of managed care on
the costs and quality of eye-care services [10]. As
MCOs seek to expand the scope of their service
offerings and employers increasingly turn to vision
health insurance companies to provide vision bene-
ﬁts, it is imperative that the impact of managed eye-
care programs on quality, cost, and patient out-
comes be evaluated.
The primary objective of this study was to assess
the impact of integrating routine and medical eye-
care services through a managed eye-care program
offered by Vision Service Plan (VSP). VSP con-
tracted with a health plan to replace the previous
system of eye care provided by the plan. Before
implementing the VSP services, the health plan cov-
ered eye exams through their contracted primary
care physicians and ophthalmologists, combined
with a program providing discounts off the cost of
eyewear through a local retail optical chain. All
medical eye-care services were provided by ophthal-
mologists, and no optometrists were part of the
health plan before VSP started providing its man-
aged eye-care program for the plan.
Once implemented by the health plan, VSP’s
managed eye-care program, known as MedVision,
integrated routine, primary, and medical eye-care
services, bringing optometrists and ophthalmolo-
gists together in a comanagement model. The model
allows patients to access their primary eye-care doc-
tor (in many cases an optometrist or an ophthal-
mologist who has chosen to act in this capacity for
the purposes of this program) for basic routine or
primary eye-care (called WellVision) services and
then to be referred to a specialist if advanced med-
ical eye-care services are necessary. Optometrists
provided medical eye care as allowed by their
license under state law.
To evaluate the impact of introducing this man-
aged eye-care program into the health plan, this
study measured rates of health services use and
costs before and after the implementation of the
program by the health plan. Patient satisfaction was
also assessed, but only after implementation of the
program.
Methods
Study Design
A pre-post analysis was conducted to evaluate the
impact of a managed eye-care program on the use
and costs of vision services. The program integrated
both routine and medical eye-care services at a sin-
gle health plan in the southeastern United States.
Speciﬁcally, routine services included visits and
exams related to checking eye health, vision acuity,
and provision of corrective lenses, whereas medical
services included services provided in relation to a
medical eye-care problem (e.g., glaucoma, cata-
racts) other than routine vision services. Appendix 1
provides a complete listing of the current proce-
dural terminology and ICD-9 diagnosis codes used
to deﬁne routine eye-care services; all other eye-care
services were considered to be medical eye care.
Medical claims and administrative data obtained
from the participating health plan and VSP was
used to identify eye-care services and costs both
before and after the implementation of the managed
eye-care program. Patient copayments for eye-care
services were the same as copayments for any other
health-care visits. Information about eye-care serv-
ices provided through the health-care plan was ana-
lyzed for two separate 18-month periods. A mail
survey was used to collect data on patient satisfac-
tion, but only among a subgroup of health plan
members following the introduction of the managed
eye-care program. No satisfaction data were avail-
able for the period before the program, because
there were no previous assessments of eye-care
services.
Patient Sample
MedVision was introduced to the health plan on
November 1, 1996. An 18-month window from
January 1, 1995, through June 30, 1996, was used
to deﬁne the comparison group to assess study out-
comes before the implementation of the managed
eye-care program. After the introduction of the
managed eye-care program, it was expected that
some patients would continue to obtain eye-care
services through their current plan. To minimize the
impact of such a transition period, the study group
was deﬁned based on an 18-month window from
January 1, 1997, through June 30, 1998.
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Patients had to be continuously enrolled in the
health plan during one or both of the 18-month
periods to be included in the analysis. The study
group consisted of health plan members continu-
ously enrolled in the health plan during the 18-
month period following the start of the managed
eye-care program, and the comparison group con-
sisted of members continuously enrolled in the
health plan during the 18-month period before its
beginning. Using these deﬁnitions, patients could be
included in both the study and the comparison
groups. Patient satisfaction was assessed through a
mail survey among a randomly selected subgroup of
study group patients who had at least one eye-care
visit for a medical problem.
Study Outcomes
The primary outcomes evaluated in this study
included use of vision care, vision costs, and patient
satisfaction with vision care. For both the study and
the comparison groups, the proportion of patients
with at least one visit was determined separately for
routine vision care and for medical vision care, as
well as the overall proportion of patients with any
type of vision care. The average number of services
per enrollee was also calculated.
Medical costs associated with the provision of
vision services were assessed from a payer per-
spective. Costs associated with vision care were
estimated based on paid medical claims plus admin-
istrative costs for the comparison group (pre-VSP)
and a prepaid per-member fee plus administrative
costs for the study group (post-VSP). Average per-
member per-month (PMPM) costs associated with
overall, routine, and medical vision services were
calculated for all patients in the study and compar-
ison groups.
A 45-item questionnaire developed for this study
was used to evaluate patient satisfaction. Aspects of
patient satisfaction assessed in this study included
overall patient satisfaction/recommendation, access
to physicians, personal care, communication, serv-
ices during the last visit, cost/value of last visit, cov-
erage of eye-care needs, coverage of expectations,
understanding and ease of eye-care coverage, and
customer service; response scales varied by ques-
tion. Nevertheless, in general patients were asked to
rate their satisfaction using a 5-point Likert-type
scale from “excellent” to “poor” or “extremely
satisﬁed” to “extremely dissatisﬁed.” Favorable
ratings were deﬁned as responses of “extremely sat-
isﬁed,” “very satisﬁed,” or “somewhat satisﬁed” or
“excellent,” “very good,” or “good.” It was not
feasible to capture satisfaction data retrospectively
for patients included in the comparison group,
because this would have required patients to assess
services that had been provided several years in the
past.
Statistical Analysis
We compared baseline demographic information
between the comparison and study groups using
Student’s t tests to assess any differences in age and
chi-square tests to assess any differences in sex. No
other patient characteristics were available in the
data. Rates of vision care were compared between
the comparison and study groups using chi-square
tests. It is important to note that because some
patients contributed data to both time periods, the
resulting P values are inexact; however, analyses
excluding these patients produced similar results
(not shown). Among patients enrolled in both
groups, McNemar’s test was used to test for differ-
ences in use of vision care services before and after
the introduction of the managed eye-care program.
The average number of routine, medical, and
overall eye-care services per enrollee during the 18-
month follow-up periods was compared between
the study and comparison groups using an unpaired
Student’s t test, and these analyses were then con-
trolled for age and sex using a general linear model.
Paired t tests were used to test for differences in the
average number of services per enrollee before and
following implementation of the managed eye-care
program among patients included in both the com-
parison and the study group. PMPM costs were
compared between the comparison and the study
groups using Student t tests, and these comparisons
were also controlled for age and sex. An additional
analysis was conducted excluding patients who
contributed data to both time periods. These
results are very similar to the ﬁndings presented
here. Among patients in both groups, PMPM costs
were compared before versus after the introduction
of the managed eye-care program using paired t
tests.
Results
Patient Characteristics
Before implementation of the managed eye-care
program, 23,816 members were continuously
enrolled in the health plan (comparison group).
Subsequent to the introduction of the managed eye-
care program, 36,168 members were enrolled in the
health plan (study group). Of these, 13,346 health
plan members were continuously enrolled during
both 18-month study periods and were included in
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both the comparison and the study groups. As
shown in Table 1, the mean enrollee age was 31 and
32 years in the comparison and study groups,
respectively. Approximately half of the patients
included in the analysis were female, and half were
male. Although the study and comparison groups
were very similar in age and sex, owing to the large
size of the groups the differences were actually sta-
tistically signiﬁcant (P < .05) although not clinically
meaningful.
Use of  Vision Services
Table 2 reports use of vision services for the com-
parison and study groups as well as for those indi-
viduals in both groups. Overall, the percentage of
patients with at least one visit for eye-care services
was lower in the study group versus comparison
group (21.9% vs. 23.1%; P = .001). Although
study group members had a higher likelihood of
having at least one routine eye-care service relative
to individuals in the comparison group (14.5% vs.
10.2%; P < .001), comparison group members had
a signiﬁcantly higher likelihood of having at least
one medical eye-care service (14.9% vs. 9.3%;
P < .001).
The overall mean number of vision services per
enrollee was lower after the introduction of Med-
Vision (0.40 vs. 0.52 services per enrollee;
P < .001). This overall difference was due to a 36%
reduction in the number of medical eye-care services
used by patients after the managed eye-care pro-
gram was introduced (from 0.33 to 0.21 services
per enrollee; P < .001). When controlled for
enrollee age and sex, the differences between the
study and comparison groups in overall number of
vision services and number of medical eye-care serv-
ices per enrollee remained signiﬁcant (P < .001).
Although not shown in Table 2, some other
ﬁndings are important. Ophthalmologists provided
most of the medical eye-care services in the com-
parison group (0.25 services per enrollee), but this
decreased substantially (to only 0.09 services per
study group enrollee) under MedVision. Optome-
trists, primary care physicians, and other practi-
tioners provided more medical eye-care services
per enrollee in the study group than in the com-
parison group. Also, both enrollee age and sex had
signiﬁcant (P < .001) effects on the number of
medical eye-care services and the overall number
of vision services. For example, the mean number
of services increased with age, from 0.32 overall
services per enrollee under 21 to 1.39 per enrollee
65 years or older. Women used more services than
men (e.g., 0.51 vs. 0.39 overall services per
enrollee).
In contrast to medical eye-care, the number of
routine eye-care services remained similar between
Table 2 Use of  vision services
Type of  eye-care service
Comparison group
(n = 23,816)
Study group
 (n = 36,168) P value*
Both† (n = 13,346)
Pre-VSP Post-VSP
Overall
Percent using services 23.1 21.9 0.001 23.9 23.7
Mean number (SD) of  
services per enrollee
0.52 (1.33) 0.40 (1.08) <0.001 0.56 (1.40) 0.42‡ (1.17)
Routine
Percent using services 10.2 14.5 <0.001 10.6 16.2‡
Mean number (SD) of  
services per enrollee
0.19 (0.60) 0.19 (0.51) 0.49 0.20 (0.63) 0.21 (0.53)
Medical
Percent using services 14.9 9.3 <0.001 15.5 10.0‡
Mean number (SD) of  
services per enrollee
0.33 (1.18) 0.21 (0.93) <0.001 0.36 (1.25) 0.21‡ (1.02)
*Comparisons between study and comparison groups were made using contingency table analysis with chi-square test for categorical variables and unpaired Student’s
t tests for continuous variables. Because some patients contributed data for both time periods, these P values are inexact; however, analyses excluding these patients
produced similar results.
†Comparisons between pre- versus post-VSP among patients included in both the study and the comparison groups were made using McNemar’s test for categorical
variables and a paired t test for continuous variables.
‡P < .001 for comparisons pre- versus post-VSP among patients included in both the study and the comparison group.
Table 1 Patient characteristics
Characteristic
Comparison group
(n = 23,816)
Study group
(n = 36,138)
Both 
(n = 13,346)
Sex (%)
Female 50.1 48.7 49.4
Male 50.0 51.3 50.6
Age (years)
Mean 30.7 31.9 31.7
SD 17.1 17.3 17.4
Age group (%)
<21 33.7 30.8 32.2
21–39 32.1 31.9 30.2
40–64 33.3 36.2 36.6
≥65 0.9 1.0 1.1
Managed Eye Care and Reduced Medical Costs 199
the study and comparison groups (0.19 routine
services per enrollee, regardless of group). Never-
theless, enrollee age and sex had signiﬁcant
(P < .001) effects on the number of routine eye-care
services. Even when controlled for age and sex, the
number of routine eye-care services still showed no
signiﬁcant difference between the study and com-
parison groups.
Findings from a separate analysis conducted on
the subgroup of patients who were included in both
the study and the comparison groups are also
reported in Table 2. The overall proportion of
patients who had at least one vision service was
almost identical during the periods before and fol-
lowing implementation of the managed eye-care
program (23.9% vs. 23.7%). Nevertheless, similar
to the overall study ﬁndings, health plan members
had a higher likelihood of having at least one visit
related to routine eye care (16.2% vs. 10.6%;
P < .001) and a decreased likelihood of having at
least one visit related to medical eye care (10.0% vs.
15.5%; P < .001) following the implementation of
the managed eye-care program. Findings related to
the mean number of vision services per enrollee in
this group of patients were consistent with the over-
all study ﬁndings. For example, there was a decrease
in the rate of medical eye-care services, such as
ofﬁce and outpatient visits, consultations, and
exams for glaucoma, cataracts, and conjunctivitis,
after MedVision was introduced. The decrease was
statistically signiﬁcant for exams for glaucoma
(P < .001), cataracts (P < .001), and conjunctivitis
(P = .007), but not signiﬁcant (i.e., P > .05) for vis-
its or consultations.
Vision Costs
Table 3 reports overall, routine, and medical
PMPM costs for the study and comparison groups
as well as for the group of patients enrolled in the
health plan during both time periods. Particularly
for medical eye-care services, the standard deviation
(SD)s of the costs was considerably larger than the
mean costs in all groups of enrollees. This is under-
standable and often observed in medical cost studies
where the majority of people did not use services
(and, hence, had $0 costs) and a relatively small
number incurred high cost.
Overall mean PMPM costs during the study
period were signiﬁcantly lower among study group
members relative to comparison group members
($1.36 vs. $1.86 PMPM; P < .001). This reduction
was driven by a 38% decrease in the aggregate costs
associated with medical eye-care services (from
$1.57 to $0.97; P < .001), a drop of almost the
same proportion as the reduction in the number of
visits per enrollee for medical eye-care services.
Conversely, the average PMPM costs for routine
eye-care services increased (from $0.29 to $0.39;
P < .001) following implementation of the managed
eye-care program. When these cost analyses were
controlled for enrollee age and sex, the differences
between the study and comparison groups remained
signiﬁcant (P £ 0.001).
Detailed results from the general linear model
analysis are presented in Table 4, which shows the
impact of the independent variables (i.e., group,
sex, and age) on each of the six main dependent var-
iables (i.e., overall use of vision services, routine
services, and medical services and PMPM cost of
overall, routine, and medical services). The coefﬁ-
cients associated with the categories that deﬁne each
independent variable are estimated separately for
each of the six regression models. Each coefﬁcient
listed in Table 4 estimates the amount associated
with the corresponding category of the independent
variable that is added to the value of the dependent
variable, when controlled by the model for the other
independent variables.
Table 3 Vision costs
Type of  eye-care
service
Comparison group
(n = 23,816)
Study group
(n = 36,138) P value*
Both† (n = 13,346)
Pre-VSP Post-VSP
Overall
Mean (PMPM $) $1.86 $1.36 <0.001 $1.90 $1.40‡
SD $17.50 $6.41 $16.34 $6.19
Routine
Mean (PMPM $) $0.29 $0.39 <0.001 $0.30 $0.41‡
SD $0.95 $0.53 $0.95 $0.59
Medical
Mean (PMPM $) $1.57 $0.97 <0.001 $1.60 $0.99‡
SD $17.48 $6.38 $16.30 $6.16
*Comparisons between study and comparison groups were made using an unpaired Student’s t test for continuous variables. Because some patients contributed data
to both time periods, these P values are inexact; however, analyses excluding these patients produced similar results.
†Comparisons between pre- vs. post-VSP among patients included in both the study and the comparison groups were made using a paired t test for continuous variables.
‡P < .001 for comparisons pre- vs. post-VSP among patients included in both the study and the comparison group.
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For example, the model for overall vision costs
has a coefﬁcient of -0.536 corresponding to the
study group (vs. the comparison group). This means
that the study group has overall PMPM vision costs
estimated to be $0.54 lower than overall costs for
the comparison groups when controlled for enrollee
age and sex. The corresponding P value (< 0.001)
shows this difference to be signiﬁcant.
The last column of Table 4 compares mean val-
ues of the dependent variable, not adjusted by the
model, for each category of the independent varia-
ble. The overall PMPM cost of $1.36 for the study
group is $0.50 lower than the cost for the compar-
ison group. These values are not adjusted for age
and sex, but the results show that the unadjusted
differences in costs between the study and compar-
ison groups are similar to the differences as adjusted
by the model and estimated by the coefﬁcients.
Table 4 also shows that enrollee age had a signiﬁ-
cant (P < .001) effect on overall, medical, and rou-
tine eye-care costs. For example, overall PMPM
costs increased for each successively older age
group, ranging from $1.14 PMPM for those under
age 21 to $4.02 PMPM for those age 65 and older.
As age increased, medical eye-care costs comprised
an increasing percentage of total eye-care costs,
ranging from 67.5% for those under age 21 to
94.5% for those age 65 and over. Sex, however, did
not have a signiﬁcant effect on overall PMPM costs
or medical eye-care costs.
When only the subgroup of patients included in
both the study and the comparison groups were
analyzed, overall and medical PMPM costs were
lower after the introduction of the managed eye-
care program, as shown in Table 3. Average PMPM
costs for routine eye-care services increased after the
Table 4 Results of  regression models and comparison of  (unadjusted) mean values
Dependent variable
used in the
model (n = 59,984)
Independent
variable/
parameter
Deﬁnition of
independent
variable df
Intercept or
coefﬁcient P value
Comparison of  mean values 
of  dependent variable for each
category of  independent variable
Use of  vision services (number of  services per person)
Overall Intercept 1 1.429 < 0.001
Group Study group
(vs. comparison)
-0.126 < 0.001 0.40 vs. 0.52
Sex Female (vs. male) 1 0.115 < 0.001 0.51 vs. 0.39
Age (years) < 21, 21–39, 40–64
(vs. 65+)
3 -1.096,
-1.048, 
-0.782
All < 0.001 0.32, 0.36,0.62 vs. 1.39
Routine Intercept 1 0.053 0.021
Group Study group
(vs. comparison)
1 0.002 0.737 0.19 vs. 0.19
Sex Female vs. male 1 0.076 < 0.001 0.23 vs. 0.15
Age (years) < 21, 21–39, 40–64
(vs. 65+)
3 0.052, 0.084,
0.149
0.026, < 0.001,
 < 0.001
0.14, 0.18,0.24 vs. 0.08
Medical Intercept 1 1.375 < 0.001
Group Study group
(vs. comparison)
1 -0.128 < 0.001 0.21 vs. 0.33
Sex Female vs. male 1 0.038 < 0.001 0.28 vs. 0.25
Age (years) < 21, 21–39, 40–64
(vs. 65+)
3 -1.148,
-1.133, 
-0.931
All < 0.001 0.17, 0.19,0.38 vs. 1.31
Vision costs (PMPM)
Overall Intercept 1 4.315 < 0.001
Group Study group
(vs. comparison)
1 -0.536 < 0.001 $1.36 vs. $1.86
Sex Female vs. male 1 0.127 0.197 $1.62 vs. $1.50
Age (years) < 21, 21–39, 40–64
(vs. 65+)
3 -2.929,
-2.842, 
-1.853
All < 0.001 $1.14, $1.21, $2.19 vs. $4.02
Routine Intercept 1 0.123 < 0.001
Group Study group
(vs. comparison)
1 0.094 < 0.001 $0.39 vs. $0.29
Sex Female vs. male 1 0.099 < 0.001 $0.40 vs. $0.30
Age (years) < 21, 21–39, 40–64
(vs. 65+)
3 0.142, 0.088,
0.137
< 0.001, 0.004,
< 0.001
$0.37, $0.32,$0.37 vs. $0.22
Medical Intercept 1 4.192 < 0.001
Group Study group
(vs. comparison)
1 -0.631 < 0.001 $0.97 vs. $1.57
Sex Female vs. male 1 0.028 0.773 $1.23 vs. $1.20
Age < 21, 21–39, 40–64
(vs. 65+)
3 -3.071,
-2.929, 
-1.989
All < 0.001 $0.77, $0.90, $1.82 vs. $3.80
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introduction of the program ($0.30 vs. $0.41;
P < .001). The differences in costs between this
patient subgroup and the full comparison and study
groups, regardless of whether considering routine,
medical, or overall eye-care costs, was only a few
pennies PMPM. The changes in costs from the
period before to the period after the managed eye-
care program started were almost identical for the
subgroup included in both the comparison and the
study groups to those for the full groups.
Patient Satisfaction
Of the 640 randomly selected patients who were
mailed a patient satisfaction survey, 276 patients
(43%) responded. Approximately 61% of the
respondents were female and 30% of respondents
were over 55 years old. The general level of satis-
faction among these patients was high. Approxi-
mately 91% or more of the patients responded
favorably to the question about overall satisfaction
with the managed eye-care plans. Further, 98% of
patients reported favorable ratings when asked
about the overall care received from their doctor.
More than 90% of patients reported favorable rat-
ings on the convenience of the doctor’s location and
ofﬁce hours, the ease of making an appointment,
ofﬁce waiting time (which was less than 30 min
among 88% of respondents), and the length of time
for a referral appointment. Approximately 92% of
respondents reported favorably on the value
received for the dollars spent on eye care.
Respondents were most satisﬁed with the level of
personal care they received, because more than
95% of patients indicated favorable ratings to all
four questions relating to friendliness, courtesy, and
quality of care provided by the doctor and the ofﬁce
staff. In comparison, respondents reported a lesser
degree of satisfaction with their understanding of
their eye-care coverage and literature (range 67–
80%). Nevertheless, 87% of respondents reported
favorably on the ease of using the managed eye-care
plan.
Discussion
The ﬁndings of this study indicate that there may be
beneﬁts to implementing an integrated managed
eye-care program in managed health-care settings.
Although overall vision services use remained simi-
lar for patients in both the comparison and the
study groups, use of routine care increased and use
of medical vision care decreased following imple-
mentation of the managed eye-care program. Over-
all vision costs decreased following the introduction
of the integrated managed eye-care program, owing
primarily to a reduction in costs associated with the
provision of medical vision services. In addition,
patients reported an overall high level of satisfac-
tion with the program and the care received from
the eye-care professionals.
There are a number of explanations for these
ﬁndings. First, by adding the managed eye-care pro-
gram to the health plan, patient access to routine
care increased. Before the introduction of the man-
aged eye-care program, a primary care physician or
an ophthalmologist for routine eye exams could see
patients as often as necessary. Nevertheless, under
the new program, patients could choose from an
additional 125 primary eye-care providers for their
routine eye-care needs, which included the follow-
ing services: eye exams, vision correction, and treat-
ment of certain types of eye conditions (e.g., eye
infections). Therefore, it is not surprising that more
than 90% of patients using the program reported
satisfaction with the locations of available doctors,
ease of scheduling appointments, wait times, and
referrals.
Second, the increase in routine services could
suggest that a signiﬁcant amount of routine services
were previously being provided as medical eye-care
through the health plan in the comparison study
period. As access to routine care increased, fewer
patients were accessing medical specialists as their
ﬁrst point of entry into the health-care system. Fur-
thermore, the program included eye-care profes-
sionals who were licensed to treat basic eye-care
conditions, which may have allowed many patients
to have their needs met at the time of their regular
exam, thus eliminating costly referrals as would
likely have been the case if a condition were diag-
nosed by a general medical provider. The decrease
in medical eye-care services for exams related to
glaucoma, cataracts, and conjunctivitis may be an
example of this change in the pattern of care.
Third, had medical eye care decreased without a
resulting rise in routine eye-care services, it is pos-
sible that patients would have felt their needs were
not being met. Had this been the case, quality-of-
care issues might have surfaced, as reﬂected by lev-
els of patient satisfaction lower than reported.
Limitations
This study has several noteworthy limitations. First,
as critics of secondary analyses assert, minimal
information can be derived from medical claims
data with certainty. The absence of clinical data pre-
cludes analyses based on severity of conditions and
makes it impossible to determine whether individu-
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als participating in the managed eye-care program
were receiving a level of care consistent with their
clinical needs. We also did not speculate on what
might constitute a recommended or expected level
of care, either for all patients or for those within
speciﬁc age groups, and cannot therefore assess
whether the amount of care provided was appropri-
ate. For example, although the rates of routine care
increased following the implementation of the man-
aged eye-care programs, it could be argued that an
even higher level of routine eye care, including
screening exams, would be advisable to detect
potential medical eye-care problems before they
became serious. Nevertheless, the observed increase
in routine care suggests that access to vision care for
these patients was not hindered by the introduction
of managed eye care. In addition, levels of patient
satisfaction among patients who were actually par-
ticipating in the managed eye-care program were
high. Although these inferences may be drawn from
medical claims data, supplemented by the patient
satisfaction survey, it is not possible to rigorously
evaluate the appropriateness of care.
Second, it was not feasible to design this study as
a randomized clinical trial. The observational
design that was used makes it impossible to know
whether the introduction of the managed eye-care
program was actually the factor responsible for the
changes in eye-care utilization and costs docu-
mented by the study. The limited nature of the avail-
able medical claims and administrative data
precluded examining the effects of patient charac-
teristics other than age and sex on changes in
eye-care utilization and costs. Nevertheless, both
demographic variables examined, particularly age,
were important in that they had signiﬁcant effects
on the outcome variables. Furthermore, when
analyses were controlled for these important varia-
bles, the changes observed in utilization and costs
after the introduction of managed eye care
remained signiﬁcant.
Even if these changes were due to the program,
we cannot determine what speciﬁc aspects of the
program inﬂuenced utilization. Certainly the
increase in number of available eye-care providers
may have made routine care more accessible, but it
is also possible that the way that the new beneﬁts
under the managed eye-care program were pro-
moted to health plan members contributed to
changes in the use of services. We simply cannot tell
what part of the program had the most impact.
Third, this evaluation was based on data from a
single health plan located in the southeastern United
States. As such, the external validity and speciﬁcally
the generalizability of these study ﬁndings to all
managed care enrollees may be limited. Neverthe-
less, the large sample sizes included in the study and
comparison groups and the fact that this study was
performed in a “real-world” clinical practice setting
without the conﬁnes of a controlled clinical trial
increase the likelihood that these ﬁndings are gen-
eralizable to the larger managed care patient popu-
lation.
Fourth, because patient satisfaction was not
measured before the health plan was changed by the
introduction of VSP’s managed eye-care program,
the impact of the program on patient satisfaction
could not be assessed. It was documented, however,
that health plan members reported a favorable
impression of the program. 
Despite the limitations of the study design, the
results suggest that the managed eye-care program
offered beneﬁts to the health plan and its members.
With primary eye-care providers working in tandem
with health plan physicians, patients accessed rou-
tine eye-care services more frequently and perhaps
had many of their needs treated at that time, ulti-
mately resulting in high patient satisfaction and a
decrease in medical eye-care utilization and total
eye-care costs. Future studies might be designed to
identify what components of the managed care pro-
gram were most effective and for which subgroups
of health plan members. Subsequent analyses pro-
viding a more complete breakdown of utilization
and costs by patient age or other characteristics
could further increase our understanding of how
managed eye care can beneﬁt a health plan.
This study was supported ﬁnancially by Vision Service
Plan, Inc.
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Appendix 1: Deﬁnition of Routine Eye Care Services in Terms of Current Procedural 
Terminology (CPT) and ICD-9 Diagnosis Codes
CPT
code
Service
description
Diagnosis
code
Diagnosis 
description
92001–5 Exam 367.0 Hypermetropia
92001–14 Exam 367.1 Myopia
92015 Refraction 367.20 Astigmatism nos
92019 Exam and treatment 367.21 Regular astigmatism
99050, 2, 4, 6 After-hours visit 367.22 Irregular astigmatism
99058 Ofﬁce emergency 367.31 Anisometropia
99201–5 Visit 367.32 Presbyopia
99211–5 Visit 367.4 Paresis of  accommodation
99241–5 Ofﬁce consultation 367.51 Tot intern ophthalmogleg
99281–3 Emergency room visit 367.52 Spasm of  accommodation
99391–6 Preventive visit 367.53 Transient refract change
367.81 Refraction disorder NEC
367.89 Refraction disorder NOS
367.9 Deprivation amblyopia
368.02 Subj visual disturb NOS
368.10 Deprivation amblyopia
368.14 Distortion of  shape/size
368.16 Psychophysic visual dist
368.51 Protan defect
368.52 Deutan defect
368.53 Tritan defect
368.54 Achromatopsia
368.55 ACQ color deﬁciency
368.59 Color deﬁciency NEC
368.60 Night blindness NOS
368.61 Congen night blindness
368.62 Acquired night blindness
368.63 ABN dark adaptat curve
368.69 Night blindness NEC
V53.1 Fit contact lens/glasses
V72.0 Eye & vision examination
